5 Biotechs Drawing Buyout Buzz in 2018 Post author:Sam Post published:January 23, 2018 Post category:BioPharma Here are five possible acquisition targets to keep an eye on. Source: BioSpace You Might Also Like Sarepta Plunged After Adverse Event Forces Trial Halt in the UK February 11, 2018 Bleeding Money, s NantHealth Restructures and Lays Off 300 August 10, 2017 Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S. October 24, 2017
Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S. October 24, 2017
